[Interference of meprobamate with adrenal hormone assays (author's transl)].
The authors draw attention to the fact that the decrease in 17-hydroxycorticosteroids and 17-ketosteroids observed in patients under meprobamate treatment is probably due to chemical interference with assay methods, since normal response to metyrapone indicates that the adrenal function is unimpaired. The asthenia usually reported by these patients is due to depression and should not be blamed on deficiency of the adrenal cortex.
D000305:Adrenal Cortex Hormones / Q000032:analysis*; D000328:Adult; D000368:Aged; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D008620:Meprobamate / Q000494:pharmacology*; D008875:Middle Aged
D000305:Adrenal Cortex Hormones; D008620:Meprobamate
Interférence du méprobamate avec le dosage des hormones cortico-surrénales.